Next Article in Journal
Impact of PCSK9 Inhibition on Proinflammatory Cytokines and Matrix Metalloproteinases Release in Patients with Mixed Hyperlipidemia and Vulnerable Atherosclerotic Plaque
Previous Article in Journal
Design, Synthesis and Molecular Docking of Novel Acetophenone-1,2,3-Triazoles Containing Compounds as Potent Enoyl-Acyl Carrier Protein Reductase (InhA) Inhibitors
Previous Article in Special Issue
Identification of a Novel Neuropeptide S Receptor Antagonist Scaffold Based on the SHA-68 Core
 
 
Review

Article Versions Notes

Pharmaceuticals 2022, 15(7), 800; https://doi.org/10.3390/ph15070800
Action Date Notes Link
article pdf uploaded. 27 June 2022 14:21 CEST Version of Record https://www.mdpi.com/1424-8247/15/7/800/pdf-vor
article xml file uploaded 28 June 2022 07:49 CEST Original file -
article xml uploaded. 28 June 2022 07:49 CEST Update https://www.mdpi.com/1424-8247/15/7/800/xml
article pdf uploaded. 28 June 2022 07:49 CEST Updated version of record https://www.mdpi.com/1424-8247/15/7/800/pdf
article html file updated 28 June 2022 07:50 CEST Original file -
article html file updated 28 June 2022 10:13 CEST Update -
article html file updated 12 August 2022 22:45 CEST Update https://www.mdpi.com/1424-8247/15/7/800/html
Back to TopTop